Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccination

11 Aug 2022

Abstract excerpt

The direct causes of dermatomyositis, a common autoimmune disease, have not yet been accurately identified, but several studies have linked this condition to various patient-associated and environmental factors, such as viral infections and area of residence. In the present report, we describe our experience with a patient presenting with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammatory Myopathies and Dermatomyositis
Share to Skin Diseases and Diabetes
Share to T-cell and B-cell Immunology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35950798
DOI: 10.1093/mrcr/rxac064

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccinationPMID 35950798Read ↗

A retrospective study for clinical characteristics of 293 patients with dermatomyositis.Semantic proximity Read ↗

Autoimmune diabetes mellitus after COVID-19 vaccination in adult population: a systematic review of case reports.Semantic proximity Read ↗

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicrySemantic proximity Read ↗

Analysis of the correlation between anti-MDA5 antibody and the severity of COVID-19: a retrospective studySemantic proximity Read ↗

Anti-melanoma differentiation-associated gene 5 (Anti-MDA5) antibody dermatomyositis: Clinical features and outcomes in a racially diverse patient cohortSemantic proximity Read ↗

Pathogenesis of Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis: A Concise Review With an Emphasis on Type I Interferon SystemSemantic proximity Read ↗

MDA5-autoimmunity and Interstitial Pneumonitis Contemporaneous with the COVID-19 Pandemic (MIP-C)Semantic proximity Read ↗

MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)Semantic proximity Read ↗

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.Semantic proximity Read ↗

Different HLA genotype pattern in patients with Multiple Sclerosis onset after COVID-19 vaccine.Semantic proximity Read ↗

Rapid Progressive Systemic Sclerosis Following mRNA COVID-19 VaccinationSemantic proximity Read ↗

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.